Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Eldery

NCT00196300 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2018-03-12

No results posted yet for this study

Summary

The objective of this study was to determine the prognostic utility of established risk predictors following acute ST elevation myocardial infarction in patients over 75 years of age.

Conditions

Sponsors & Collaborators

  • Deutsches Herzzentrum Muenchen

    lead OTHER

Principal Investigators

  • Georg Schmidt, MD · Deutsches Herzzentrum Muenchen

  • Petra Barthel, MD · Deutsches Herzzentrum Muenchen

  • Axel Bauer, MD · Deutsches Herzzentrum Muenchen

Eligibility

Min Age
76 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00196300 on ClinicalTrials.gov